कृपया अन्य खोज का प्रयास करें
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Gilla Kaplan | 75 | 2019 | Independent Director |
Isan Chen | 60 | 2020 | Independent Director |
Siddarth Subramony | 35 | 2020 | Independent Director |
Melissa McCracken | 34 | 2021 | Independent Director |
Jake Simson | 36 | 2020 | Independent Director |
Rehan Verjee | 42 | 2021 | Independent Director |
Nina S. Kjellson | 47 | 2018 | Independent Director |
Brian Schwartz | 60 | - | Scientific Advisor |
Peter G. Smith | - | - | Scientific Advisor |
Jason Sheltzer | - | - | Scientific Advisor |
William C. Hahn | - | - | Scientific Advisor |
Jeffrey Hager | 58 | - | Scientific Advisor |
Robert J. More | 55 | 2018 | Independent Director |
Todd Harris | 44 | 2018 | Co-Founder, President, CEO, Secretary, Treasurer & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है